nodes	percent_of_prediction	percent_of_DWPC	metapath
Metyrosine—Hypervigilance—Methotrexate—colon cancer	0.104	0.141	CcSEcCtD
Metyrosine—TH—blood vessel—colon cancer	0.0877	0.38	CbGeAlD
Metyrosine—Speech impairment NOS—Fluorouracil—colon cancer	0.0657	0.0897	CcSEcCtD
Metyrosine—TH—embryo—colon cancer	0.0523	0.227	CbGeAlD
Metyrosine—TH—renal system—colon cancer	0.0396	0.172	CbGeAlD
Metyrosine—Salivation—Irinotecan—colon cancer	0.0386	0.0528	CcSEcCtD
Metyrosine—Speech impairment NOS—Methotrexate—colon cancer	0.0342	0.0467	CcSEcCtD
Metyrosine—TH—digestive system—colon cancer	0.0325	0.141	CbGeAlD
Metyrosine—Parkinsonism—Fluorouracil—colon cancer	0.0316	0.0431	CcSEcCtD
Metyrosine—Trismus—Capecitabine—colon cancer	0.03	0.041	CcSEcCtD
Metyrosine—TH—lymph node—colon cancer	0.0185	0.0804	CbGeAlD
Metyrosine—Speech disorder—Irinotecan—colon cancer	0.0174	0.0238	CcSEcCtD
Metyrosine—Speech disorder—Fluorouracil—colon cancer	0.0167	0.0228	CcSEcCtD
Metyrosine—Salivary hypersecretion—Irinotecan—colon cancer	0.0145	0.0199	CcSEcCtD
Metyrosine—Ibuprofen—PPARG—colon cancer	0.012	0.323	CrCbGaD
Metyrosine—Swelling—Fluorouracil—colon cancer	0.0118	0.0161	CcSEcCtD
Metyrosine—Disorientation—Fluorouracil—colon cancer	0.0116	0.0159	CcSEcCtD
Metyrosine—Aspartate aminotransferase increased—Vincristine—colon cancer	0.0101	0.0137	CcSEcCtD
Metyrosine—Aspartate aminotransferase increased—Irinotecan—colon cancer	0.00979	0.0134	CcSEcCtD
Metyrosine—Dysuria—Vincristine—colon cancer	0.00902	0.0123	CcSEcCtD
Metyrosine—Eosinophilia—Fluorouracil—colon cancer	0.00891	0.0122	CcSEcCtD
Metyrosine—Erectile dysfunction—Vincristine—colon cancer	0.00889	0.0121	CcSEcCtD
Metyrosine—Speech disorder—Methotrexate—colon cancer	0.00868	0.0118	CcSEcCtD
Metyrosine—Acetaminophen—PTGS2—colon cancer	0.00851	0.229	CrCbGaD
Metyrosine—Swelling—Capecitabine—colon cancer	0.00825	0.0113	CcSEcCtD
Metyrosine—Hallucination—Vincristine—colon cancer	0.00769	0.0105	CcSEcCtD
Metyrosine—Acetaminophen—ABCB1—colon cancer	0.00723	0.195	CrCbGaD
Metyrosine—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.00655	0.00895	CcSEcCtD
Metyrosine—Anaemia—Vincristine—colon cancer	0.00622	0.00849	CcSEcCtD
Metyrosine—Anaemia—Irinotecan—colon cancer	0.00605	0.00826	CcSEcCtD
Metyrosine—Dysuria—Capecitabine—colon cancer	0.00588	0.00803	CcSEcCtD
Metyrosine—Anaemia—Fluorouracil—colon cancer	0.0058	0.00792	CcSEcCtD
Metyrosine—Confusional state—Irinotecan—colon cancer	0.00539	0.00736	CcSEcCtD
Metyrosine—Thrombocytopenia—Vincristine—colon cancer	0.00537	0.00734	CcSEcCtD
Metyrosine—Haematuria—Capecitabine—colon cancer	0.00535	0.0073	CcSEcCtD
Metyrosine—Thrombocytopenia—Irinotecan—colon cancer	0.00523	0.00714	CcSEcCtD
Metyrosine—Confusional state—Fluorouracil—colon cancer	0.00516	0.00705	CcSEcCtD
Metyrosine—Ibuprofen—PTGS2—colon cancer	0.00505	0.136	CrCbGaD
Metyrosine—Thrombocytopenia—Fluorouracil—colon cancer	0.00501	0.00684	CcSEcCtD
Metyrosine—Insomnia—Vincristine—colon cancer	0.00496	0.00678	CcSEcCtD
Metyrosine—Oedema peripheral—Capecitabine—colon cancer	0.00496	0.00677	CcSEcCtD
Metyrosine—Insomnia—Irinotecan—colon cancer	0.00483	0.0066	CcSEcCtD
Metyrosine—Fatigue—Vincristine—colon cancer	0.00473	0.00646	CcSEcCtD
Metyrosine—Eosinophilia—Methotrexate—colon cancer	0.00464	0.00633	CcSEcCtD
Metyrosine—Insomnia—Fluorouracil—colon cancer	0.00463	0.00632	CcSEcCtD
Metyrosine—Fatigue—Irinotecan—colon cancer	0.00461	0.00629	CcSEcCtD
Metyrosine—Gastrointestinal pain—Vincristine—colon cancer	0.00449	0.00613	CcSEcCtD
Metyrosine—Feeling abnormal—Irinotecan—colon cancer	0.0044	0.00601	CcSEcCtD
Metyrosine—Dysuria—Methotrexate—colon cancer	0.00438	0.00598	CcSEcCtD
Metyrosine—Gastrointestinal pain—Irinotecan—colon cancer	0.00437	0.00597	CcSEcCtD
Metyrosine—Abdominal pain—Vincristine—colon cancer	0.00434	0.00592	CcSEcCtD
Metyrosine—Erectile dysfunction—Methotrexate—colon cancer	0.00431	0.00589	CcSEcCtD
Metyrosine—Ibuprofen—ABCB1—colon cancer	0.0043	0.116	CrCbGaD
Metyrosine—Abdominal pain—Irinotecan—colon cancer	0.00423	0.00577	CcSEcCtD
Metyrosine—Feeling abnormal—Fluorouracil—colon cancer	0.00422	0.00576	CcSEcCtD
Metyrosine—Tremor—Capecitabine—colon cancer	0.00411	0.00561	CcSEcCtD
Metyrosine—Urticaria—Fluorouracil—colon cancer	0.00407	0.00555	CcSEcCtD
Metyrosine—Anaemia—Capecitabine—colon cancer	0.00405	0.00553	CcSEcCtD
Metyrosine—Hypersensitivity—Vincristine—colon cancer	0.00404	0.00552	CcSEcCtD
Metyrosine—Haematuria—Methotrexate—colon cancer	0.00398	0.00544	CcSEcCtD
Metyrosine—Hypersensitivity—Irinotecan—colon cancer	0.00394	0.00538	CcSEcCtD
Metyrosine—Asthenia—Vincristine—colon cancer	0.00394	0.00538	CcSEcCtD
Metyrosine—Asthenia—Irinotecan—colon cancer	0.00383	0.00524	CcSEcCtD
Metyrosine—Hypersensitivity—Fluorouracil—colon cancer	0.00377	0.00515	CcSEcCtD
Metyrosine—Diarrhoea—Vincristine—colon cancer	0.00375	0.00513	CcSEcCtD
Metyrosine—Anxiety—Capecitabine—colon cancer	0.00372	0.00508	CcSEcCtD
Metyrosine—Diarrhoea—Irinotecan—colon cancer	0.00366	0.00499	CcSEcCtD
Metyrosine—Dry mouth—Capecitabine—colon cancer	0.00365	0.00498	CcSEcCtD
Metyrosine—Confusional state—Capecitabine—colon cancer	0.00361	0.00492	CcSEcCtD
Metyrosine—Diarrhoea—Fluorouracil—colon cancer	0.0035	0.00478	CcSEcCtD
Metyrosine—Thrombocytopenia—Capecitabine—colon cancer	0.0035	0.00478	CcSEcCtD
Metyrosine—Vomiting—Vincristine—colon cancer	0.00349	0.00476	CcSEcCtD
Metyrosine—Headache—Vincristine—colon cancer	0.00344	0.00469	CcSEcCtD
Metyrosine—Vomiting—Irinotecan—colon cancer	0.0034	0.00464	CcSEcCtD
Metyrosine—Headache—Irinotecan—colon cancer	0.00335	0.00457	CcSEcCtD
Metyrosine—Nausea—Vincristine—colon cancer	0.00326	0.00445	CcSEcCtD
Metyrosine—Vomiting—Fluorouracil—colon cancer	0.00325	0.00444	CcSEcCtD
Metyrosine—Insomnia—Capecitabine—colon cancer	0.00324	0.00442	CcSEcCtD
Metyrosine—Headache—Fluorouracil—colon cancer	0.00321	0.00438	CcSEcCtD
Metyrosine—Nausea—Irinotecan—colon cancer	0.00317	0.00433	CcSEcCtD
Metyrosine—Fatigue—Capecitabine—colon cancer	0.00308	0.00421	CcSEcCtD
Metyrosine—Nausea—Fluorouracil—colon cancer	0.00304	0.00415	CcSEcCtD
Metyrosine—Anaemia—Methotrexate—colon cancer	0.00302	0.00412	CcSEcCtD
Metyrosine—Feeling abnormal—Capecitabine—colon cancer	0.00295	0.00402	CcSEcCtD
Metyrosine—Gastrointestinal pain—Capecitabine—colon cancer	0.00293	0.00399	CcSEcCtD
Metyrosine—Urticaria—Capecitabine—colon cancer	0.00284	0.00388	CcSEcCtD
Metyrosine—Abdominal pain—Capecitabine—colon cancer	0.00283	0.00386	CcSEcCtD
Metyrosine—Confusional state—Methotrexate—colon cancer	0.00269	0.00367	CcSEcCtD
Metyrosine—Hypersensitivity—Capecitabine—colon cancer	0.00264	0.0036	CcSEcCtD
Metyrosine—Thrombocytopenia—Methotrexate—colon cancer	0.00261	0.00356	CcSEcCtD
Metyrosine—Asthenia—Capecitabine—colon cancer	0.00257	0.0035	CcSEcCtD
Metyrosine—Diarrhoea—Capecitabine—colon cancer	0.00245	0.00334	CcSEcCtD
Metyrosine—Insomnia—Methotrexate—colon cancer	0.00241	0.00329	CcSEcCtD
Metyrosine—Fatigue—Methotrexate—colon cancer	0.0023	0.00313	CcSEcCtD
Metyrosine—Vomiting—Capecitabine—colon cancer	0.00227	0.00311	CcSEcCtD
Metyrosine—Headache—Capecitabine—colon cancer	0.00224	0.00306	CcSEcCtD
Metyrosine—Feeling abnormal—Methotrexate—colon cancer	0.00219	0.003	CcSEcCtD
Metyrosine—Gastrointestinal pain—Methotrexate—colon cancer	0.00218	0.00297	CcSEcCtD
Metyrosine—Nausea—Capecitabine—colon cancer	0.00212	0.0029	CcSEcCtD
Metyrosine—Urticaria—Methotrexate—colon cancer	0.00212	0.00289	CcSEcCtD
Metyrosine—Abdominal pain—Methotrexate—colon cancer	0.00211	0.00287	CcSEcCtD
Metyrosine—Hypersensitivity—Methotrexate—colon cancer	0.00196	0.00268	CcSEcCtD
Metyrosine—Asthenia—Methotrexate—colon cancer	0.00191	0.00261	CcSEcCtD
Metyrosine—Diarrhoea—Methotrexate—colon cancer	0.00182	0.00249	CcSEcCtD
Metyrosine—Vomiting—Methotrexate—colon cancer	0.00169	0.00231	CcSEcCtD
Metyrosine—Headache—Methotrexate—colon cancer	0.00167	0.00228	CcSEcCtD
Metyrosine—Nausea—Methotrexate—colon cancer	0.00158	0.00216	CcSEcCtD
